Immediately after birth |
Prenatal diagnosis warranting special care |
Significant prematurity (less than 34 to 35 weeks' gestation) |
Intrauterine growth restriction |
Twin-to-twin transfusion syndrome |
Clinically significant congenital anomalies |
Rh sensitization |
Maternal conditions (e.g., drug use, diabetes) |
Maternal medications resulting in neonatal depression (e.g., opiates for pain control, magnesium sulfate) |
Risk factors for sepsis (e.g., clinical chorioamnionitis) |
Delivery complications |
Asphyxia, low 5-minute Apgar score, prolonged resuscitation |
Placental abruption, placenta previa, vasa previa |
Early postnatal period |
Cardiorespiratory |
| Poor peripheral perfusion (slow capillary refill, low blood pressure) |
| Respiratory distress (grunting, tachypnea more than 60 breaths per minute, intercostal retractions) |
| Cyanosis (congenital heart disease) |
| Apnea and/or cyanotic episodes |
Gastrointestinal |
| Feeding intolerance |
| No meconium passage by 24 hours of age |
| Bilious vomiting |
Neurologic |
| Seizures |
| Signs of drug withdrawal |
| Poor tone |
| Lethargy |
Jaundice |
| Any visible jaundice at less than 24 hours of age |
| Clinically significant, age-specific hyperbilirubinemia |
| Rate of rise of bilirubin more than 0.5 mg per dL (8.55 μmol per L) per hour |
Metabolic and others |
| Temperature instability (consistently below 36.4°C [97.5°F]) |
| Low blood glucose level (less than 45 mg per dL [2.5 mmol per L]) or high blood glucose level (more than 180 mg per dL [10.0 mmol per L]) |
| Petechiae and purpura |
| Clinically significant congenital anomalies |